Senior Director, Communications
The Technical Consortium for DNA Synthesis Screening, convened by NTI | bio and the World Economic Forum (WEF), responded to the U.S. government’s request for comment on its Revised Screening Framework Guidance for Providers and Users of Synthetic Oligonucleotides.
NTI | bio team members join hundreds of global health security experts from around the world in Singapore for the second Global Health Security Conference.
NTI and the Vienna Center for Disarmament and Nonproliferation (VCDNP) co-hosted a meeting on June 7, 2022 to explore the possibility of establishing a new “Joint Assessment Mechanism” to strengthen UN-system capabilities to investigate high-consequence biological events of unknown origin.
NTI | bio and the World Economic Forum (WEF) convened the third annual meeting of the Technical Consortium on DNA Synthesis Screening on May 12-13, 2022.
NTI Co-Chairman and CEO Ernest J. Moniz and Munich Security Conference (MSC) Chairman Ambassador Wolfgang Ischinger virtually convened 19 global leaders and experts on February 17, 2022 for a high-level tabletop exercise focused on reducing high-consequence biological threats.
Sign up for our newsletter to get the latest on nuclear and biological threats.
NTI experts bring years of experience at the highest levels of government and research to tackle nuclear, chemical, biological and radiological threats.